Free Trial

Haleon (LON:HLN) Trading Down 1.9% - Time to Sell?

Haleon logo with Medical background
Remove Ads

Haleon plc (LON:HLN - Get Free Report)'s stock price was down 1.9% on Monday . The stock traded as low as GBX 382.60 ($4.95) and last traded at GBX 385.50 ($4.99). Approximately 14,722,720 shares traded hands during trading, a decline of 48% from the average daily volume of 28,321,533 shares. The stock had previously closed at GBX 393.15 ($5.09).

Analyst Upgrades and Downgrades

Separately, Berenberg Bank raised their price objective on Haleon from GBX 456 ($5.90) to GBX 457 ($5.92) and gave the stock a "buy" rating in a research report on Friday, February 28th.

View Our Latest Research Report on Haleon

Haleon Trading Up 0.1 %

The business's 50-day simple moving average is GBX 386.58 and its 200-day simple moving average is GBX 381.74. The company has a market cap of £34.52 billion, a PE ratio of 32.17, a P/E/G ratio of 1.49 and a beta of 0.19. The company has a current ratio of 0.84, a quick ratio of 0.93 and a debt-to-equity ratio of 53.36.

Haleon (LON:HLN - Get Free Report) last announced its quarterly earnings data on Friday, February 28th. The company reported GBX 15.80 ($0.20) earnings per share (EPS) for the quarter. Haleon had a return on equity of 6.54% and a net margin of 9.66%. As a group, analysts expect that Haleon plc will post 19.5033282 EPS for the current fiscal year.

Remove Ads

Haleon Increases Dividend

The company also recently declared a dividend, which will be paid on Thursday, June 5th. Stockholders of record on Thursday, April 24th will be issued a dividend of GBX 4.60 ($0.06) per share. This represents a dividend yield of 1.18%. This is a positive change from Haleon's previous dividend of $2.00. The ex-dividend date is Thursday, April 24th. Haleon's payout ratio is currently 50.46%.

Haleon Company Profile

(Get Free Report)

Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.

Featured Stories

Should You Invest $1,000 in Haleon Right Now?

Before you consider Haleon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.

While Haleon currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Will Tesla’s Robot Future Save Its Falling Stock?

Will Tesla’s Robot Future Save Its Falling Stock?

Tesla’s Future Is Robots, Not EVs? Renowned tech expert Jeff Brown shares why he believes Tesla’s biggest business will be robotics, not electric vehicles.

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up
Tesla Sinks on Musk Drama—Bounce or Bigger Crash?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads